Refrigeration and cryopreservation of platelets differentially affect platelet metabolism and function: a comparison with conventional platelet storage conditions

Transfusion

Volumn 56, Issue 7, 2016, Pages 1807-1818

  Johnson, Lacey ^a   Tan, Shereen ^a   Wood, Ben ^a,b   Davis, April ^a   Marks, Denese C ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE;

ARTICLE; BLOOD CLOTTING; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRESERVATION; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE PHOSPHORYLATION; PLATELET MICROPARTICLE; REFRIGERATION; ROOM TEMPERATURE; THAWING; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE METABOLISM; THROMBOCYTE PRESERVATION; THROMBOCYTE SHAPE; THROMBOELASTOGRAPHY;

EID: 84977602287     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13630     Document Type: Article

References (63)

1. Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability—deleterious effect of refrigerated storage. N Engl J Med 1969;280:1094-8.
2. Schiffer CA, Aisner J, Wiernik PH. Clinical experience with transfusion of cryopreserved platelets. Br J Haematol 1976;34:377-85.
3. Holley A, Marks DC, Johnson L, et al. Frozen blood products: clinically effective and potentially ideal for remote Australia. Anaesth Intensive Care 2013;41:10-9.
4. Lelkens CC, Koning JG, De Kort B, et al. Experiences with frozen blood products in the Netherlands military. Transfus Apher Sci 2006;34:289-98.
5. Badloe J, Noorman F. The Netherlands experience with frozen −80°C red cells, plasma and platelets in combat casualty care [abstract]. Transfusion 2011;51 Suppl:24A.
6. Cap AP. Platelet storage: a license to chill! Transfusion 2016;56:13-6.
7. Valeri CR, Macgregor H, Ragno G. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension. Transfusion 2005;45:596-603.
8. Dumont LJ, Cancelas JA, Dumont DF, et al. A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxide–frozen autologous platelets in healthy volunteers. Transfusion 2013;53:128-37.
9. Johnson L, Reade MC, Hyland RA, et al. In vitro comparison of cryopreserved and liquid platelets: potential clinical implications. Transfusion 2015;55:838-47.
10. Sandgren P, Hansson M, Gulliksson H, et al. Storage of buffy-coat-derived platelets in additive solutions at 4°C and 22°C: flow cytometry analysis of platelet glycoprotein expression. Vox Sang 2007;93:27-36.
11. Sandgren P, Shanwell A, Gulliksson H. Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C. Transfusion 2006;46:828-34.
12. Khuri SF, Healey N, Macgregor H, et al. Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999;117:172-83.
13. Becker G, Tuccelli M, Kunicki T, et al. Studies of platelet concentrates stored at 22°C and 4°C. Transfusion 1973;13:61-8.
14. Reddoch KM, Pidcoke HF, Montgomery RK, et al. Hemostatic function of apheresis platelets stored at 4°C and 22°C. Shock 2014;41 Suppl 1:54-61.
15. Filip DJ, Aster RH. Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. J Lab Clin Med 1978;91:618-24.
16. Johnson L, Coorey CP, Marks DC. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion 2014;54:1917-26.
17. Getz TM, Montgomery RK, Bynum JA, et al. Storage of platelets at 4°C in platelet additive solutions prevents aggregate formation and preserves platelet functional responses. Transfusion 2016;56:1320–8.
18. Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell 2003;112:87-97.
19. Hornsey VS, Drummond O, Mcmillan L, et al. Cold storage of pooled, buffy-coat-derived, leucoreduced platelets in plasma. Vox Sang 2008;95:26-32.
20. Johnson L, Reid S, Tan S, et al. PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma. Transfusion 2013;53:2268-77.
21. Raynel S, Padula MP, Marks DC, et al. Cryopreservation alters the membrane and cytoskeletal protein profile of platelet microparticles. Transfusion 2015;55:2422-32.
22. Labrie A, Marshall A, Bedi H, et al. Characterization of platelet concentrates using dynamic light scattering. Transfus Med Hemother 2013;40:93-100.
23. Johnson L, Winter KM, Hartkopf-Theis T, et al. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution. Transfusion 2012;52:503-9.
24. Maurer-Spurej E, Chipperfield K. Past and future approaches to assess the quality of platelets for transfusion. Transfus Med Rev 2007;21:295-306.
25. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical excellence for safer transfusion working party of the international society of blood transfusion. Transfusion 1998;38:31-40.
26. Chan KS, Sparrow RL. Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold. Transfusion 2014;54:1935-44.
27. Lawrie AS, Harrison P, Cardigan RA, et al. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008;95:197-204.
28. Spinella PC, Dunne J, Beilman GJ, et al. Constant challenges and evolution of US military transfusion medicine and blood operations in combat. Transfusion 2012;52:1146-53.
29. Van Der Meer PF, Kerkhoffs JL, Curvers J, et al. In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang 2010;98:517-24.
30. Tynngård N, Trinks M, Berlin G. In vitro properties of platelets stored in three different additive solutions. Transfusion 2012;52:1003-9.
31. Zhu M, Xu W, Wang BL, et al. Hemostatic function and transfusion efficacy of apheresis platelet concentrates treated with gamma irradiation in use for thrombocytopenic patients. Transfus Med Hemother 2014;41:189-96.
32. Tynngård N, Studer M, Lindahl TL, et al. The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days. Transfusion 2008;48:1669-75.
33. Van Aelst B, Feys HB, Devloo R, et al. Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro. Vox Sang 2015;108:328-39.
34. Marrocco C, D'Alessandro A, Girelli G, et al. Proteomic analysis of platelets treated with gamma irradiation versus a commercial photochemical pathogen reduction technology. Transfusion 2013;53:1808-20.
35. Skripchenko A, Gelderman MP, Awatefe H, et al. Automated cold temperature cycling improves in vitro platelet properties and in vivo recovery in a mouse model compared to continuous cold storage. Transfusion 2016;56:24-32.
36. Hoffmeister KM, Falet H, Toker A, et al. Mechanisms of cold-induced platelet actin assembly. J Biol Chem 2001;276:24751-9.
37. Cardigan R, Turner C, Harrison P. Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang 2005;88:153-63.
38. Kunicki TJ, Tuccelli M, Becker GA, et al. A study of variables affecting the quality of platelets stored at “room temperature.” Transfusion 1975;15:414-21.
39. Maurer-Spurej E, Labrie A, Pittendreigh C, et al. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Transfusion 2009;49:2276-84.
40. Hervig T, Sandberg V, Titlestad A, et al. Dynamic light-scattering score and platelet transfusion outcomes [abstract]. Transfusion 2014;54 Suppl 2:73A.
41. Doery JC, Hirsh J, Cooper I. Energy metabolism in human platelets: interrelationship between glycolysis and oxidative metabolism. Blood 1970;36:159-68.
42. Gulliksson H. Platelet storage media. Vox Sang 2014;107:205-12.
43. Guppy M, Whisson ME, Sabaratnam R, et al. Alternative fuels for platelet storage: a metabolic study. Vox Sang 1990;59:146-52.
44. Bertolini F, Murphy S, Rebulla P, et al. Role of acetate during platelet storage in a synthetic medium. Transfusion 1992;32:152-6.
45. Murphy S, Shimizu T, Miripol J. Platelet storage for transfusion in synthetic media: further optimization of ingredients and definition of their roles. Blood 1995;86:3951-60.
46. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 17th ed. Strasbourg, France: Council of Europe Publishing; 2013.
47. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 2003;122:10-23.
48. Murphy S, Gardner FH. Platelet storage at 22 degrees C: role of gas transport across plastic containers in maintenance of viability. Blood 1975;46:209-18.
49. Solberg C, Holme S, Little C. Morphological changes associated with pH changes during storage of platelet concentrates in first-generation 3-day container. Vox Sang 1986;50:71-7.
50. Badlou BA, Ijseldijk MJ, Smid WM, et al. Prolonged platelet preservation by transient metabolic suppression. Transfusion 2005;45:214-22.
51. Kahn RA, Syring RL. The fate of bacteria introduced into whole blood from which platelet concentrates were prepared and stored at 22 or 4C. Transfusion 1975;15:363-7.
52. Currie LM, Harper JR, Allan H, et al. Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4 degrees C with retention of in vitro functional activity. Transfusion 1997;37:18-24.
53. Li J, Goodrich L, Hansen E, et al. Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage. Transfusion 2005;45:1750-8.
54. Penefsky HS, Warner RC. Partial resolution of the enzymes catalyzing oxidative phosphorylation. VI. Studies on the mechanism of cold inactivation of mitochondrial adenosine triphosphatase. J Biol Chem 1965;240:4694-702.
55. Skripchenko A, Myrup A, Thompson-Montgomery D, et al. Periods without agitation diminish platelet mitochondrial function during storage. Transfusion 2010;50:390-9.
56. Hunter S, Nixon J, Murphy S. The effect of the interruption of agitation on platelet quality during storage for transfusion. Transfusion 2001;41:809-14.
57. Holmsen H, Setkowsky CA, Day HJ. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platelets. Biochem J 1974;144:385-96.
58. Nair PM, Pidcoke HF, Cap AP, et al. Effect of cold storage on shear-induced platelet aggregation and clot strength. J Trauma Acute Care Surg 2014;77:S88-93.
59. Mondoro TH, Vostal JG. Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents. Platelets 2002;13:11-20.
60. Turner VS, Hawker RJ, Mitchell SG, et al. Paired in vivo and in vitro comparison of apheresis and “recovered” platelet concentrates stored for 5 days. J Clin Apher 1994;9:189-94.
61. Bikker A, Bouman E, Sebastian S, et al. Functional recovery of stored platelets after transfusion. Transfusion 2016;56:1030–7.
62. Owens M, Holme S, Heaton A, et al. Post-transfusion recovery of function of 5-day stored platelet concentrates. Br J Haematol 1992;80:539-44.
63. Harr JN, Moore EE, Chin TL, et al. Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg 2013;74:756-65.